Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Shapiro

Showing results (881-890 of 1,171) with videos related to

Pageof 118
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2022
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II StudyVivek Subbiah, Irene Braña, Alessandra Longhi, et al.
Annals of Emergency Medicine|April 6, 2010
The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsisNathan I Shapiro, Stephen Trzeciak, Judd E Hollander, et al.
Oral Oncology|July 4, 2012
Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancerMissak Haigentz, Mimi Kim, Catherine Sarta, et al.
American Journal of Physiology. Renal Physiology|November 23, 2007
Partial nephrectomy as a model for uremic cardiomyopathy in the mouseDavid J Kennedy, Jihad Elkareh, Amjad Shidyak, et al.
Ebiomedicine|June 23, 2016
A Broad-Spectrum Infection Diagnostic that Detects Pathogen-Associated Molecular Patterns (PAMPs) in Whole BloodMark Cartwright, Martin Rottman, Nathan I Shapiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2014
DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survivalLiam Cornell, Joanne M Munck, Clara Alsinet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2015
First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced CancerGeoffrey I Shapiro, Katherine M Bell-McGuinn, Julian R Molina, et al.
American Journal of Respiratory and Critical Care Medicine|May 7, 2026
Effects of an early restrictive versus liberal fluid strategy on long-term patient-centered outcomes in sepsis-induced hypotension (SHAMROC): an open-label, randomized controlled trialAnselm Jorda, Georg Gelbenegger, Nathan I Shapiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
JAMA Network Open|August 8, 2019
Long-term Host Immune Response Trajectories Among Hospitalized Patients With SepsisSachin Yende, John A Kellum, Victor B Talisa, et al.
Pageof 118

Showing results (881-890 of 1,171) with videos related to

Sort By:
Pageof 118
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2022
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II StudyVivek Subbiah, Irene Braña, Alessandra Longhi, et al.
Annals of Emergency Medicine|April 6, 2010
The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsisNathan I Shapiro, Stephen Trzeciak, Judd E Hollander, et al.
Oral Oncology|July 4, 2012
Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancerMissak Haigentz, Mimi Kim, Catherine Sarta, et al.
American Journal of Physiology. Renal Physiology|November 23, 2007
Partial nephrectomy as a model for uremic cardiomyopathy in the mouseDavid J Kennedy, Jihad Elkareh, Amjad Shidyak, et al.
Ebiomedicine|June 23, 2016
A Broad-Spectrum Infection Diagnostic that Detects Pathogen-Associated Molecular Patterns (PAMPs) in Whole BloodMark Cartwright, Martin Rottman, Nathan I Shapiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2014
DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survivalLiam Cornell, Joanne M Munck, Clara Alsinet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2015
First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced CancerGeoffrey I Shapiro, Katherine M Bell-McGuinn, Julian R Molina, et al.
American Journal of Respiratory and Critical Care Medicine|May 7, 2026
Effects of an early restrictive versus liberal fluid strategy on long-term patient-centered outcomes in sepsis-induced hypotension (SHAMROC): an open-label, randomized controlled trialAnselm Jorda, Georg Gelbenegger, Nathan I Shapiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
JAMA Network Open|August 8, 2019
Long-term Host Immune Response Trajectories Among Hospitalized Patients With SepsisSachin Yende, John A Kellum, Victor B Talisa, et al.
Pageof 118